77 related articles for article (PubMed ID: 2742782)
1. Interferon treatment in patients with malignant carcinoids.
Nobin A; Lindblom A; Månsson B; Sundberg M
Acta Oncol; 1989; 28(3):445-9. PubMed ID: 2742782
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
Ahren B; Engman K; Lindblom A
Anticancer Res; 1992; 12(1):129-33. PubMed ID: 1567158
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to long-term treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
Ahren B; Engman K; Lindblom A
Anticancer Res; 1992; 12(3):881-4. PubMed ID: 1622146
[TBL] [Abstract][Full Text] [Related]
4. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome.
Oberg K; Funa K; Alm G
N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.
Funa K; Alm GV; Rönnblom L; Oberg K
Clin Exp Immunol; 1983 Sep; 53(3):716-24. PubMed ID: 6616963
[TBL] [Abstract][Full Text] [Related]
6. Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide.
Creutzfeldt W; Bartsch HH; Jacubaschke U; Stöckmann F
Acta Oncol; 1991; 30(4):529-35. PubMed ID: 1713038
[TBL] [Abstract][Full Text] [Related]
7. Treatment of malignant endocrine pancreatic tumors with human leukocyte interferon.
Eriksson B; Oberg K; Alm G; Karlsson A; Lundqvist G; Magnusson A; Wide L; Wilander E
Cancer Treat Rep; 1987 Jan; 71(1):31-7. PubMed ID: 2878718
[TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.
Oberg K; Norheim I; Lind E; Alm G; Lundqvist G; Wide L; Jonsdottir B; Magnusson A; Wilander E
Cancer Treat Rep; 1986 Nov; 70(11):1297-304. PubMed ID: 2429764
[TBL] [Abstract][Full Text] [Related]
9. Effect of interferon on T1 relaxation times of liver metastases from endocrine gastrointestinal tumours.
Andersson T; Eriksson B; Hemmingsson A; Jung B; Lindh E; Thuomas KA; Oberg K
Acta Radiol; 1988; 29(1):21-5. PubMed ID: 2964840
[TBL] [Abstract][Full Text] [Related]
10. Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumors.
Andersson T; Wilander E; Eriksson B; Lindgren PG; Oberg K
Cancer Res; 1990 Jun; 50(11):3413-5. PubMed ID: 2334936
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon].
Doberauer C; Niederle N; Kloke O; Kurschel E; Schmidt CG
Onkologie; 1987 Dec; 10(6):340-4. PubMed ID: 2450326
[TBL] [Abstract][Full Text] [Related]
12. Chemoembolization in the treatment of metastatic ileocolic carcinoid.
Diculescu M; Atanasiu C; Arbănaş T; Croitoru A; Mihalcea A; Becheanu G; Costinean S; Gheorghe L; Capşa R
Rom J Gastroenterol; 2002 Jun; 11(2):141-7. PubMed ID: 12145671
[TBL] [Abstract][Full Text] [Related]
13. [131I]metaiodobenzylguanidine therapy in carcinoid tumors.
Castellani MR; Di Bartolomeo M; Maffioli L; Zilembo N; Gasparini M; Buraggi GL
J Nucl Biol Med (1991); 1991; 35(4):349-51. PubMed ID: 1823855
[TBL] [Abstract][Full Text] [Related]
14. Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization.
Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO
Scand J Gastroenterol; 1989 Sep; 24(7):787-95. PubMed ID: 2477894
[TBL] [Abstract][Full Text] [Related]
15. Combined alpha- and gamma-interferon therapy for malignant midgut carcinoid tumors. A phase I-II trial.
Janson ET; Kauppinen HL; Oberg K
Acta Oncol; 1993; 32(2):231-3. PubMed ID: 8323762
[TBL] [Abstract][Full Text] [Related]
16. [Chemical embolization of carcinoid metastases in the liver].
Grote R; Schmoll E; Döhring W; Rosenthal H; Reimer P; Dralle H
Rofo; 1990 Nov; 153(5):595-600. PubMed ID: 2173070
[TBL] [Abstract][Full Text] [Related]
17. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
Kirkwood JM; Harris JE; Vera R; Sandler S; Fischer DS; Khandekar J; Ernstoff MS; Gordon L; Lutes R; Bonomi P
Cancer Res; 1985 Feb; 45(2):863-71. PubMed ID: 3881175
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
19. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
[TBL] [Abstract][Full Text] [Related]
20. Role of [131I]metaiodobenzylguanidine therapy in carcinoids.
Hoefnagel CA; Taal BG; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):346-8. PubMed ID: 1726678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
